Literature DB >> 28438994

Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.

Hao Li1, Xing-Xing Wang1, Bin Wang2, Lei Fu2, Guan Liu3, Yu Lu2, Min Cao3, Hairong Huang4, Babak Javid5.   

Abstract

The role of Igs in natural protection against infection by Mycobacterium tuberculosis (Mtb), the causative agent of TB, is controversial. Although passive immunization with mAbs generated against mycobacterial antigens has shown protective efficacy in murine models of infection, studies in B cell-depleted animals only showed modest phenotypes. We do not know if humans make protective antibody responses. Here, we investigated whether healthcare workers in a Beijing TB hospital-who, although exposed to suprainfectious doses of pathogenic Mtb, remain healthy-make antibody responses that are effective in protecting against infection by Mtb. We tested antibodies isolated from 48 healthcare workers and compared these with 12 patients with active TB. We found that antibodies from 7 of 48 healthcare workers but none from active TB patients showed moderate protection against Mtb in an aerosol mouse challenge model. Intriguingly, three of seven healthcare workers who made protective antibody responses had no evidence of prior TB infection by IFN-γ release assay. There was also good correlation between protection observed in vivo and neutralization of Mtb in an in vitro human whole-blood assay. Antibodies mediating protection were directed against the surface of Mtb and depended on both immune complexes and CD4+ T cells for efficacy. Our results indicate that certain individuals make protective antibodies against Mtb and challenge paradigms about the nature of an effective immune response to TB.

Entities:  

Keywords:  TB; TB restrictors; antibodies; humoral immunity; immune complex

Mesh:

Substances:

Year:  2017        PMID: 28438994      PMCID: PMC5441709          DOI: 10.1073/pnas.1611776114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.

Authors:  Miglena G Prabagar; Hyeong-jwa Choi; Jin-Yeon Park; Sohee Loh; Young-Sun Kang
Journal:  Clin Exp Med       Date:  2013-09-01       Impact factor: 3.984

2.  Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis.

Authors:  Ashwin S Dharmadhikari; Randall J Basaraba; Martie L Van Der Walt; Karin Weyer; Matsie Mphahlele; Kobus Venter; Paul A Jensen; Melvin W First; Sydney Parsons; David N McMurray; Ian M Orme; Edward A Nardell
Journal:  Tuberculosis (Edinb)       Date:  2011-04-07       Impact factor: 3.131

3.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

4.  Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity.

Authors:  Jiaoyu Deng; Lijun Bi; Lin Zhou; Shu-juan Guo; Joy Fleming; He-wei Jiang; Ying Zhou; Jia Gu; Qiu Zhong; Zong-xiu Wang; Zhonghui Liu; Rui-ping Deng; Jing Gao; Tao Chen; Wenjuan Li; Jing-fang Wang; Xude Wang; Haicheng Li; Feng Ge; Guofeng Zhu; Hai-nan Zhang; Jing Gu; Fan-lin Wu; Zhiping Zhang; Dianbing Wang; Haiying Hang; Yang Li; Li Cheng; Xiang He; Sheng-ce Tao; Xian-en Zhang
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

5.  A Functional Role for Antibodies in Tuberculosis.

Authors:  Lenette L Lu; Amy W Chung; Tracy R Rosebrock; Musie Ghebremichael; Wen Han Yu; Patricia S Grace; Matthew K Schoen; Fikadu Tafesse; Constance Martin; Vivian Leung; Alison E Mahan; Magdalena Sips; Manu P Kumar; Jacquelynne Tedesco; Hannah Robinson; Elizabeth Tkachenko; Monia Draghi; Katherine J Freedberg; Hendrik Streeck; Todd J Suscovich; Douglas A Lauffenburger; Blanca I Restrepo; Cheryl Day; Sarah M Fortune; Galit Alter
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

6.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

7.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

Authors:  Amy W Chung; Manu P Kumar; Kelly B Arnold; Wen Han Yu; Matthew K Schoen; Laura J Dunphy; Todd J Suscovich; Nicole Frahm; Caitlyn Linde; Alison E Mahan; Michelle Hoffner; Hendrik Streeck; Margaret E Ackerman; M Juliana McElrath; Hanneke Schuitemaker; Maria G Pau; Lindsey R Baden; Jerome H Kim; Nelson L Michael; Dan H Barouch; Douglas A Lauffenburger; Galit Alter
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

9.  Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Authors:  Tingting Chen; Caroline Blanc; Anke Z Eder; Rafael Prados-Rosales; Ana Camila Oliveira Souza; Ryung S Kim; Aharona Glatman-Freedman; Maju Joe; Yu Bai; Todd L Lowary; Rachel Tanner; Michael J Brennan; Helen A Fletcher; Helen McShane; Arturo Casadevall; Jacqueline M Achkar
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

10.  Over-Expression of the Mycobacterial Trehalose-Phosphate Phosphatase OtsB2 Results in a Defect in Macrophage Phagocytosis Associated with Increased Mycobacterial-Macrophage Adhesion.

Authors:  Hao Li; Mei Wu; Yan Shi; Babak Javid
Journal:  Front Microbiol       Date:  2016-11-04       Impact factor: 5.640

View more
  51 in total

Review 1.  Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Authors:  Jacqueline M Achkar; Rafael Prados-Rosales
Journal:  Curr Opin Immunol       Date:  2018-04-12       Impact factor: 7.486

Review 2.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 3.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

Review 4.  Th1 cytokines, true functional signatures for protective immunity against TB?

Authors:  Gucheng Zeng; Guoliang Zhang; Xinchun Chen
Journal:  Cell Mol Immunol       Date:  2017-11-20       Impact factor: 11.530

5.  Immune stability predicts tuberculosis infection risk in a wild mammal.

Authors:  Mauricio Seguel; Brianna R Beechler; Courtney C Coon; Paul W Snyder; Johannie M Spaan; Anna E Jolles; Vanessa O Ezenwa
Journal:  Proc Biol Sci       Date:  2019-10-02       Impact factor: 5.349

6.  Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Authors:  Tingting Chen; Caroline Blanc; Yanyan Liu; Elise Ishida; Sarah Singer; Jiayong Xu; Maju Joe; Elizabeth R Jenny-Avital; John Chan; Todd L Lowary; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 7.  The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis.

Authors:  Rainer Kalscheuer; Ainhoa Palacios; Itxaso Anso; Javier Cifuente; Juan Anguita; William R Jacobs; Marcelo E Guerin; Rafael Prados-Rosales
Journal:  Biochem J       Date:  2019-07-18       Impact factor: 3.857

Review 8.  Antibody-based vaccine strategies against intracellular pathogens.

Authors:  Arturo Casadevall
Journal:  Curr Opin Immunol       Date:  2018-04-25       Impact factor: 7.486

Review 9.  Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.

Authors:  Joel D Ernst
Journal:  Cell Host Microbe       Date:  2018-07-11       Impact factor: 21.023

Review 10.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.